See the following AlzForum article, including comments at the bottom from independent researchers.
Finally: Big Win on All Outcomes for Lecanemab in Phase 3 Topline Results:
Another good-news story - this time for A... - Cure Parkinson's
Another good-news story - this time for Alzheimer's disease - Lecanemab (an anti-amyloid antibody) achieves some success in a Phase 3 trial
Written by
jeffreyn
To view profiles and participate in discussions please or .
1 Reply
•
Yes, the big question for us is does this mean the amyloid theory bears weight? (So would removing the Alpha synuclein for PD have therpudic benefits also). Maybe there's hope!
Not what you're looking for?
You may also like...
Phase 3 Positive Topline Results for Tavapadon
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial...
Buntanetape updates
a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases...
ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE
https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=e4e0b40
Cure Parkinson’s and Van Andel Institute announce funding for a phase 1 clinical trial of low-dose lithium in Parkinson’s disease
Cure Parkinson’s and Van Andel Institute announce funding for a phase 1 clinical trial of...
Inosine, Israpidine, NAC, Glutathione clinical trials - Love to hear from those who have experience with these.
Inosine and NAC trials are still open.
Glutathione trial complete (I would like to see the......
Related Posts
Update on Affiris Vaccine - Phase 1 results
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107,ERK inhibitor that selectively inhibits neuroinflammation- Ambroxol Phase 2 results
Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
Ambroxol cough suppressant repurposed for slow down progression or hopefully stop PD
